Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 1 G
SDP

Supplier:  Medchemexpress LLC HY1533671G

Encompass_Preferred

FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9). It targets ncBAF and can be used for research on a wide range of cancers that contain a mutation in a BAF complex subunit. When combined with Telomelysin or INO5401, FHD-609 may have a role in adrenocortical carcinoma (ACC) treatment.

  • PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9).
  • Targets ncBAF.
  • Applicable for research into cancers with a mutation in a BAF complex subunit.
  • Potential for adrenocortical carcinoma (ACC) treatment in combination with Telomelysin or INO5401.
  • Purity: 98.95%.
  • Molecular weight: 829.00.
  • Formula: C47H56N8O6.
  • Appearance: Solid, white to off-white.

Catalog No. 50-003-73522


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.